Related Experiment Videos

Clinical significance of homocysteine in elderly hospitalized patients

José Juan Viña Rodríguez1, Francisco Santolaria, Antonio Martínez-Riera

  • 1Servicio de Medicina Interna, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife 38320, Spain.

Insights

Low serum homocysteine levels in elderly hospitalized patients may indicate malnutrition and inflammation, signaling a poor prognosis. These levels should not be misinterpreted as protective factors in this vulnerable population.

Area of Science:

  • Gerontology
  • Clinical Biochemistry
  • Internal Medicine

Background:

  • Serum homocysteine is an aging-related vascular risk factor linked to heart failure and dementia.
  • Low homocysteine levels can be an adverse prognostic factor in dialysis patients.
  • The prognostic value of homocysteine in elderly hospitalized patients requires further investigation.

Purpose of the Study:

  • To analyze the prevalence, clinical significance, and prognostic value of serum homocysteine levels in elderly patients (>65 years) admitted to a general internal medicine unit.

Main Methods:

  • A cohort of 337 hospitalized elderly patients and 36 controls were studied.
  • Demographics, medical history, vascular risk factors, BMI, and biochemical parameters (cholesterol, triglycerides, folate, vitamin B12, homocysteine) were recorded.
  • Survival status of 301 patients was assessed post-discharge using Kaplan-Meier survival analysis.

Main Results:

  • Serum homocysteine positively correlated with age, creatinine, and albumin; negatively with cobalamin and folate.
  • Higher homocysteine levels were observed in patients with heart failure or cognitive impairment.
  • Both abnormally low and high homocysteine levels were associated with increased mortality, linked to malnutrition and inflammation.

Conclusions:

  • Low serum homocysteine in non-vitamin-supplemented elderly hospitalized patients may signal an inflammatory-malnutrition process.
  • This condition is associated with a poor prognosis and should not be considered protective.
  • Homocysteine levels in this population reflect complex interactions rather than a simple vascular risk factor.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...